Page last updated: 2024-11-07

paramethasone and Myasthenia Gravis

paramethasone has been researched along with Myasthenia Gravis in 1 studies

Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eisen, AA1
Norris, JW1

Reviews

1 review available for paramethasone and Myasthenia Gravis

ArticleYear
Adrenal steroid therapy in neurological disease. Part I.
    Canadian Medical Association journal, 1969, Jan-04, Volume: 100, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Arteritis; Arthritis, Rheumatoid; Col

1969